IL88148A0 - Somatotropin sustained release formulations - Google Patents
Somatotropin sustained release formulationsInfo
- Publication number
- IL88148A0 IL88148A0 IL88148A IL8814888A IL88148A0 IL 88148 A0 IL88148 A0 IL 88148A0 IL 88148 A IL88148 A IL 88148A IL 8814888 A IL8814888 A IL 8814888A IL 88148 A0 IL88148 A0 IL 88148A0
- Authority
- IL
- Israel
- Prior art keywords
- somatotropin
- sustained release
- release formulations
- formulations
- sustained
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000013268 sustained release Methods 0.000 title 1
- 239000012730 sustained-release form Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878725427A GB8725427D0 (en) | 1987-10-30 | 1987-10-30 | Somatotropin formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL88148A0 true IL88148A0 (en) | 1989-06-30 |
Family
ID=10626158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL88148A IL88148A0 (en) | 1987-10-30 | 1988-10-25 | Somatotropin sustained release formulations |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0314421A1 (da) |
| JP (1) | JPH01149732A (da) |
| KR (1) | KR890006224A (da) |
| CN (1) | CN1032743A (da) |
| AU (1) | AU618760B2 (da) |
| DK (1) | DK597388A (da) |
| GB (1) | GB8725427D0 (da) |
| HU (1) | HUT48467A (da) |
| IL (1) | IL88148A0 (da) |
| MX (1) | MX26698A (da) |
| NZ (1) | NZ226723A (da) |
| PH (1) | PH25793A (da) |
| PT (1) | PT88859A (da) |
| ZA (1) | ZA888067B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0422290A1 (en) * | 1989-10-09 | 1991-04-17 | Eli Lilly And Company | Novel drug delivery system |
| AU653325B2 (en) * | 1990-02-12 | 1994-09-29 | Lucky Limited | A composition durably releasing bioactive polypeptides |
| YU87892A (sh) * | 1991-10-01 | 1995-12-04 | Eli Lilly And Company Lilly Corporate Center | Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu |
| KR19990071255A (ko) | 1998-02-28 | 1999-09-15 | 성재갑 | 소마토트로핀과 비타민의 합제 조성물 |
| KR20090007504A (ko) * | 2000-02-24 | 2009-01-16 | 몬산토 테크놀로지 엘엘씨 | 소마토트로핀의 지속적인 방출을 위한 비수성 주사제제들 |
| US6946137B2 (en) * | 2001-10-19 | 2005-09-20 | Idexx Laboratories, Inc. | Methods for the controlled delivery of pharmacologically active compounds |
| EP1446103B1 (en) * | 2001-10-19 | 2015-12-23 | Idexx Laboratories, Inc. | Injectable compositions for the controlled delivery of pharmacologically active compound |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1155036A (en) * | 1966-07-08 | 1969-06-11 | Ethan Allan Brown | Injectionable Substance |
| DE3484584D1 (de) * | 1983-10-14 | 1991-06-20 | Sumitomo Pharma | Injektionen mit verzoegerter abgabe. |
| KR890002631B1 (ko) * | 1984-10-04 | 1989-07-21 | 몬산토 캄파니 | 생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물 |
| EP0193917A3 (en) * | 1985-03-06 | 1987-09-23 | American Cyanamid Company | Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration |
| EP0211601A3 (en) * | 1985-07-30 | 1988-01-13 | International Minerals And Chemical Corporation | Stabilization of growth promoting hormones |
| US4775659A (en) * | 1985-08-19 | 1988-10-04 | Eli Lilly And Company | Injectable semi-solid formulations |
| IL79765A (en) * | 1985-08-23 | 1992-02-16 | Lilly Co Eli | Injectable sustained release formulations of bovine somatotropin |
| ES2039219T3 (es) * | 1986-08-11 | 1993-09-16 | American Cyanamid Company | Composiciones para administracion parenteral y su uso. |
-
1987
- 1987-10-30 GB GB878725427A patent/GB8725427D0/en active Pending
-
1988
- 1988-10-25 MX MX2669888A patent/MX26698A/es unknown
- 1988-10-25 AU AU24313/88A patent/AU618760B2/en not_active Ceased
- 1988-10-25 IL IL88148A patent/IL88148A0/xx unknown
- 1988-10-25 EP EP88309997A patent/EP0314421A1/en not_active Withdrawn
- 1988-10-26 NZ NZ226723A patent/NZ226723A/en unknown
- 1988-10-26 KR KR1019880013950A patent/KR890006224A/ko not_active Application Discontinuation
- 1988-10-26 PT PT88859A patent/PT88859A/pt not_active Application Discontinuation
- 1988-10-27 PH PH37734A patent/PH25793A/en unknown
- 1988-10-27 ZA ZA888067A patent/ZA888067B/xx unknown
- 1988-10-27 CN CN88107461A patent/CN1032743A/zh active Pending
- 1988-10-27 DK DK597388A patent/DK597388A/da not_active Application Discontinuation
- 1988-10-28 JP JP63272854A patent/JPH01149732A/ja active Pending
- 1988-10-28 HU HU885635A patent/HUT48467A/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR890006224A (ko) | 1989-06-12 |
| DK597388A (da) | 1989-05-01 |
| AU2431388A (en) | 1989-05-04 |
| PT88859A (pt) | 1989-07-31 |
| NZ226723A (en) | 1991-04-26 |
| DK597388D0 (da) | 1988-10-27 |
| ZA888067B (en) | 1990-06-27 |
| AU618760B2 (en) | 1992-01-09 |
| JPH01149732A (ja) | 1989-06-12 |
| EP0314421A1 (en) | 1989-05-03 |
| CN1032743A (zh) | 1989-05-10 |
| HUT48467A (en) | 1989-06-28 |
| GB8725427D0 (en) | 1987-12-02 |
| PH25793A (en) | 1991-11-05 |
| MX26698A (es) | 1993-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA886284B (en) | Controlled release formulations | |
| NZ225101A (en) | Sustained release composition | |
| AR243378A1 (es) | Procedimiento para preparar una formulacion farmaceutica de liberacion prolongada. | |
| ZA878499B (en) | Transdermal contraceptive formulations | |
| AR243376A1 (es) | Un procedimiento para preparar medicamentos tableteados. | |
| GB8724763D0 (en) | Sustained-release formulations | |
| PH24205A (en) | Sustained release dosage forms | |
| AU7942087A (en) | Sustained release formulations | |
| IL88148A0 (en) | Somatotropin sustained release formulations | |
| IE871503L (en) | Sustained release formulations | |
| ZA881843B (en) | Somatotropin prolonged release | |
| GB8924207D0 (en) | Formulations | |
| ZA896012B (en) | Controlled release formulations | |
| IE883255L (en) | Somatotropin formulations | |
| GB8729673D0 (en) | Formulations | |
| SG27194G (en) | Sustained release etodaloc | |
| GB8922061D0 (en) | Controlled release formulations | |
| IE860577L (en) | Sustained release composition | |
| IE872675L (en) | Sustained release pharmaceutical | |
| GB8823107D0 (en) | Formulations | |
| GB8826942D0 (en) | Formulations | |
| GB8803654D0 (en) | Formulations | |
| GB8803653D0 (en) | Formulations | |
| GB8826941D0 (en) | Formulations | |
| GB8815091D0 (en) | Formulations |